EB-1020 (Centanafadine) 328.8 mg: clinical trials recruiting now

Fewer than 3 recruiting trials found.

Phase breakdown

Conditions being studied

Recruiting trials involving EB-1020 (Centanafadine) 328.8 mg

• A Long-term Trial of EB-1020 in Adult Patients With ADHD
  NCT06926829 · Phase: Phase 3 · Ages: 18 Years to 55 Years · Sex: All (male and female) · 1 location
• Evaluation of the Efficacy and Safety of EB-1020 in Adult ADHD Patients
  NCT06931080 · Phase: Phase 2, Phase 3 · Ages: 18 Years to 55 Years · Sex: All (male and female) · 1 location

Common questions

How many recruiting trials involve EB-1020 (Centanafadine) 328.8 mg?

2 recruiting trials across 2 conditions.

Is this list of trials complete?

No. For the full record, search ClinicalTrials.gov.